Science Explorer Back to mapMap
Discussion
Company · Jacksonville · United States

Nonagen Bioscience (United States)

nonagen.comROR OpenAlex
Research works
16
▲ 226% vs 2018-21
Citations
605
38.6 per fractional work
Top-10% rate
6.0%
all institutions 10.0%
Open access
72%
world 40%
International
24%
world 18%
Nonagen Bioscience (United States)

Not ranked overall: Nonagen Bioscience (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Nonagen Bioscience (United States) work in?

In all years, 49% of research at Nonagen Bioscience (United States) is in Health Sciences, 38% in Life Sciences. Its largest fields are Medicine (48%), Biochemistry, Genetics and Molecular Biology (28%), Engineering (9%). It does 1.7× the world's share of Life Sciences.

Health Sciences: 8 fractional works · 48.6% of its workMedicine: 8 fractional works · 48.3% of its workSurgery: 3 fractional works · 18.3% of its workOncology: 2 fractional works · 9.6% of its workPulmonary and Respiratory Medicine: 1 fractional works · 6.3% of its workEpidemiology: 1 fractional works · 4.2% of its workGastroenterology: 0 fractional works · 2.1% of its workPathology and Forensic Medicine: 0 fractional works · 2.1% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 1.4% of its workPsychiatry and Mental health: 0 fractional works · 1.1% of its workUrology: 0 fractional works · 1.1% of its workImmunology and Allergy: 0 fractional works · 0.7% of its workHematology: 0 fractional works · 0.4% of its workNephrology: 0 fractional works · 0.4% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workVeterinary: 0 fractional works · 0.3% of its workSmall Animals: 0 fractional works · 0.3% of its workLife Sciences: 6 fractional works · 37.7% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 28.5% of its workMolecular Biology: 3 fractional works · 20.8% of its workCancer Research: 1 fractional works · 4.9% of its workCell Biology: 0 fractional works · 1.4% of its workEndocrinology: 0 fractional works · 1.1% of its workSmaller subfields together: 0 fractional works · 0.3% of its workImmunology and Microbiology: 1 fractional works · 8.2% of its workImmunology: 1 fractional works · 8.2% of its workNeuroscience: 0 fractional works · 1.1% of its workCellular and Molecular Neuroscience: 0 fractional works · 1.1% of its workPhysical Sciences: 2 fractional works · 13.0% of its workEngineering: 1 fractional works · 9.4% of its workBiomedical Engineering: 1 fractional works · 9.1% of its workElectrical and Electronic Engineering: 0 fractional works · 0.3% of its workChemistry: 1 fractional works · 3.6% of its workSpectroscopy: 1 fractional works · 3.6% of its workSocial Sciences: 0 fractional works · 0.6% of its workArts and Humanities: 0 fractional works · 0.4% of its workArcheology: 0 fractional works · 0.4% of its workDecision Sciences: 0 fractional works · 0.3% of its workInformation Systems and Management: 0 fractional works · 0.3% of its workALL ITS WORKNonagenBioscience…16fractional works, all years
Life Sciences38%Physical Sciences13%Health Sciences49%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 9 fields, with their numbers
    1. Medicine848.3%
    2. Veterinary00.3%
    1. Biochemistry, Genetics and Molecular Biology428.5%
    2. Immunology and Microbiology18.2%
    3. Neuroscience01.1%
    1. Engineering19.4%
    2. Chemistry13.6%
    1. Arts and Humanities00.4%
    2. Decision Sciences00.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 3.03× its world share, 1 worksBiochemistry, Geneti…Engineering: 2.13× its world share, 1 worksEngineeringMedicine: 2.58× its world share, 2 worksMedicineVeterinary: 6.06× its world share, 0 worksVeterinaryArts and Humanities: 0.21× its world share, 0 worksArts and HumanitiesDecision Sciences: 0.85× its world share, 0 worksDecision Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 6.1×. Every wedge is a field page.

All 6 fields, with their numbers
  1. Veterinary6.06×0 works
  2. Biochemistry, Genetics and Molecular Biology3.03×1 works
  3. Medicine2.58×2 works
  4. Engineering2.13×1 works
  5. Decision Sciences0.85×0 works
  6. Arts and Humanities0.21×0 works

What are the most cited papers from Nonagen Bioscience (United States)?

The most cited paper from Nonagen Bioscience (United States) is "Expression of CXCL1 in human endothelial cells induces angiogenesis through the CXCR2 receptor and the ERK1/2 and EGF pathways" (Makito Miyake, Steve Goodison, Virginia Urquidi et al., 2013), with 150 citations. Next come "A Multi-Analyte Assay for the Non-Invasive Detection of Bladder Cancer" (109) and "Angiogenin promotes tumoral growth and angiogenesis by regulating matrix metallopeptidase-2 expression via the ERK1/2 pathway" (105).

Most cited papers
#PaperReleasedCitations
1 Expression of CXCL1 in human endothelial cells induces angiogenesis through the CXCR2 receptor and the ERK1/2 and EGF pathways Makito Miyake, Steve Goodison, Virginia Urquidi et al. · Laboratory Investigation Open access 3 Jun 2013 150
2 A Multi-Analyte Assay for the Non-Invasive Detection of Bladder Cancer Steve Goodison, Myron N. Chang, Yunfeng E. Dai et al. · PLoS ONE Open access 19 Oct 2012 109
3 Angiogenin promotes tumoral growth and angiogenesis by regulating matrix metallopeptidase-2 expression via the ERK1/2 pathway Makito Miyake, Steve Goodison, Adrienne Lawton et al. · Oncogene Open access 24 Feb 2014 105
4 Matrix metalloproteinase-10 promotes tumor progression through regulation of angiogenic and apoptotic pathways in cervical tumors Ge Zhang, Makito Miyake, Adrienne Lawton et al. · BMC Cancer Open access 3 May 2014 99
5 Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors Rocio García‐Carbonero et al. · Journal for ImmunoTherapy of Cancer Open access Mar 2022 92
All 46 most cited papers, with filters and sorting

Which research topics does Nonagen Bioscience (United States) publish most on?

By volume in 2022-now: Bladder and Urothelial Cancer Treatments, Biosensors and Analytical Detection, Molecular Biology Techniques and Applications and Liver Disease Diagnosis and Treatment.

Bladder and Urothelial C…1Bladder and Urothelial Cancer Treatments: 1 fractional worksBiosensors and Analytica…1Biosensors and Analytical Detection: 1 fractional worksMolecular Biology Techniques and Applications: 0 fractional worksLiver Disease Diagnosis …0Liver Disease Diagnosis and Treatment: 0 fractional worksNanoplatforms for cancer…0Nanoplatforms for cancer theranostics: 0 fractional worksEnterobacteriaceae and C…0Enterobacteriaceae and Cronobacter Research: 0 fractional worksAdvanced Chemical Sensor Technologies: 0 fractional worksUrinary Tract Infections Management: 0 fractional worksUrinary Bladder and Prostate Research: 0 fractional worksbioluminescence and chemiluminescence research: 0 fractional works
SurgeryBiomedical EngineeringMolecular BiologyEpidemiology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Bladder and Urothelial Cancer Treatments Surgery 1 works
  2. 2 Biosensors and Analytical Detection Biomedical Engineering 1 works
  3. 3 Molecular Biology Techniques and Applications Molecular Biology 0 works
  4. 4 Liver Disease Diagnosis and Treatment Epidemiology 0 works
  5. 5 Nanoplatforms for cancer theranostics Biomedical Engineering 0 works
  6. 6 Enterobacteriaceae and Cronobacter Research Endocrinology 0 works
  7. 7 Advanced Chemical Sensor Technologies Biomedical Engineering 0 works
  8. 8 Urinary Tract Infections Management Epidemiology 0 works
  9. 9 Urinary Bladder and Prostate Research Urology 0 works
  10. 10 bioluminescence and chemiluminescence research Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available72.2%not open27.8%

World: 40% of research is openly available.

with international co-authors24.1%domestic only75.9%

World: 18% is written across borders.

How has Nonagen Bioscience (United States)'s research output changed?

Output in 2022-2025 was 226% higher than in 2018-2021.

still counting2010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Nonagen Bioscience (United States) as a percentage of every work published that year, 0.000041% in 2024.

still counting0.000050%0.00010%0.00015%Nonagen Bioscience (United States)0.000023% in 202520102020

Fractional works of Nonagen Bioscience (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Jacksonville

All research institutions in Jacksonville

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Nonagen Bioscience (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.